Emory heart team implants new blood-pumping device for first time in U.S.
Business Announcement
Updates every hour. Last Updated: 17-May-2025 14:09 ET (17-May-2025 18:09 GMT/UTC)
On Nov. 18, the heart failure and transplantation team at Emory University Hospital (EUH) made history, performing the first-ever surgical implantation in the United States of a brand-new type of ventricular assist device (VAD), which provides crucial care to patients with failing hearts. An expert team led by veteran cardiothoracic surgeon Mani Daneshmand, MD, successfully implanted a novel magnetically levitated pump, a VAD that has been specifically designed for patient ease and long-term health. As part of the INNOVATE clinical trial, Emory will participate in gathering data on patient experience with the device, joined by other leading medical institutions across the country, including Cleveland Clinic Foundation, Duke University and University of Chicago.
The Journal of Dental Research (JDR) has announced the publication of a new issue of Advances in Dental Research, a supplement to the Journal of Dental Research (JDR), entitled, "Women in Dental, Clinical, and Translational Research.”
Routine screening to detect risk factors for heart disease dropped sharply during the COVID-19 pandemic in England, and some key measurements, such as blood pressure readings, may still lag behind pre-pandemic levels. These findings are reported in a new study by Frederick Ho and Naveed Sattar of the University of Glasgow, Scotland, UK, and colleagues published November 26th in the open-access journal PLOS Medicine.
There is evidence that alcohol consumption is influenced by prenatal sex steroids so experts from Swansea University and colleagues from the Medical University of Lodz decided to use a sample of students for their research into the subject.